Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net income | $84.1M | $32.3M | $47.3M | $50.9M | $60.5M |
| EPS (diluted) | $3.69 | $1.34 | $1.88 | $1.96 | $2.18 |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | $141M | -$62.4M | -$169M | -$153M | -$579M |
| Capital expenditures | $0.00 | $11.0K | $458K | $439K | $106K |
| Free cash flow | $141M | -$62.4M | -$170M | -$153M | -$579M |
| Share buybacks | — | $0.00 | $0.00 | $402K | $0.00 |
| Dividends paid | $70.1M | $64.5M | $14.1M | $20.3M | $28.0M |
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $187M | $126M | $184M | $381M | $310M |
| Total assets | — | $999M | $1.43B | $2.06B | $2.74B |
| Total liabilities | — | $624M | $1.18B | $1.76B | $2.35B |
| Long-term debt | — | $539M | $644M | $708M | $820M |
| Shareholders' equity | $404M | $375M | $249M | $296M | $398M |
| Retained earnings | — | $20.6M | $28.1M | $57.8M | $95.0M |
| Shares (wtd avg diluted) | 22.8M | 24.2M | 24.3M | 25.2M | 26.7M |
Every figure is extracted from NewtekOne, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.